Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBO-MS: CBT, Modafinil, and Combination for MS Fatigue
NCT03621761Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Nov 2018
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of modafinil in multiple sclerosis (MS) (3 arms), sponsored by University of Michigan. Primary endpoint: Modified Fatigue Impact Scale at 12 weeks. Started Nov 2018; status: completed.
02
Drugs
modafinil
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03621761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03621761.